Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 1 | 2021 | 2 | 0.680 |
Why?
|
| Sex Characteristics | 1 | 2021 | 36 | 0.660 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2017 | 6 | 0.530 |
Why?
|
| Lung Diseases | 1 | 2017 | 7 | 0.530 |
Why?
|
| Cell Membrane | 2 | 2013 | 43 | 0.410 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 3 | 0.400 |
Why?
|
| Ceramides | 1 | 2013 | 3 | 0.400 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2013 | 4 | 0.400 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 7 | 0.400 |
Why?
|
| Enzyme Activation | 1 | 2013 | 36 | 0.400 |
Why?
|
| Endothelial Cells | 1 | 2013 | 16 | 0.400 |
Why?
|
| Animals | 6 | 2021 | 1349 | 0.340 |
Why?
|
| Mice | 4 | 2021 | 465 | 0.260 |
Why?
|
| Mice, Knockout | 2 | 2021 | 103 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2021 | 54 | 0.170 |
Why?
|
| Capillary Permeability | 2 | 2013 | 5 | 0.160 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 222 | 0.150 |
Why?
|
| Humans | 3 | 2021 | 5837 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 7 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 87 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2013 | 15 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 29 | 0.110 |
Why?
|
| Male | 3 | 2021 | 3399 | 0.110 |
Why?
|
| Platelet Activating Factor | 1 | 2013 | 3 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 3 | 0.100 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2013 | 4 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2013 | 48 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 57 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 71 | 0.100 |
Why?
|
| Female | 1 | 2021 | 3346 | 0.100 |
Why?
|
| Lung | 2 | 2005 | 31 | 0.070 |
Why?
|
| Nitric Oxide | 2 | 2005 | 24 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2005 | 4 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 17 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Vesicular Transport Proteins | 1 | 2005 | 5 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 5 | 0.060 |
Why?
|
| Cadherins | 1 | 2005 | 11 | 0.060 |
Why?
|
| Chemokines | 1 | 2002 | 2 | 0.050 |
Why?
|
| Sepsis | 1 | 2002 | 25 | 0.050 |
Why?
|
| Caveolae | 1 | 2005 | 2 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2005 | 4 | 0.010 |
Why?
|
| Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2005 | 1 | 0.010 |
Why?
|
| Glycerol | 1 | 2005 | 2 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2005 | 2 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 4 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 9 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 11 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 4 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 11 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 12 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 31 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 46 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 51 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 17 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 43 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 36 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 167 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 101 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 66 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Lung Injury | 1 | 2002 | 1 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2002 | 5 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2002 | 6 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 7 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 7 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 11 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 27 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 31 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 2002 | 13 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 122 | 0.010 |
Why?
|